Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sigma-Aldrich Corporation    SIAL   US8265521018

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/17/2014 10/20/2014 10/21/2014 10/22/2014 10/23/2014 Date
134.03(c) 134.99(c) 135.6(c) 135.85(c) 135.38(c) Last
1 544 750 865 675 936 833 700 960 1 024 653 Volume
-0.28% +0.72% +0.45% +0.18% -0.35% Change
More quotes
Company
Sigma-Aldrich Corp. operates as a life science and technology material company.It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals.The company's biochemical and organic chemical products are used in scientific research, including genomic and... 
Sector
Specialty Chemicals
Calendar
10/23Earnings Release
Surperformance© rating of Sigma-Aldrich Corporation
Trading Rating : Investor Rating :
More about the company
Chart SIGMA-ALDRICH CORPORATION
Duration : Period :
Sigma-Aldrich Corporation Technical Analysis Chart | SIAL | US8265521018 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 786 M
EBIT 2014 718 M
Net income 2014 508 M
Debt 2014 275 M
Yield 2014 0,68%
Sales 2015 2 897 M
EBIT 2015 755 M
Net income 2015 552 M
Debt 2015 442 M
Yield 2015 0,71%
PER 2014 32,14
PER 2015 29,49
EV / Sales 2014 5,88x
EV / Sales 2015 5,71x
Capitalization 16 107 M
More Financials
Latest news on SIGMA-ALDRICH CORPORATION
1d ago SIGMA ALDRICH : Management's Discussion and Analysis of Financial Condition and ..
1d ago SIGMA ALDRICH : meets 3Q profit forecasts
1d ago SIGMA ALDRICH : Results of Operations and Financial Condition, Financial Stateme..
1d ago SIGMA ALDRICH : NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Millio..
1d ago SIGMA ALDRICH : NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Millio..
2d ago SIGMA ALDRICH : BioReliance® Introduces Advanced In Vitro ADME and Toxicology Se..
2d ago SIGMA ALDRICH : SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit I..
4d agoSIGMA-ALDRICH CORPORATION : quaterly earnings release
4d ago SIGMA ALDRICH : BioReliance Introduces Advanced In Vitro ADME and Toxicology Ser..
10/16 SIGMA ALDRICH : BioReliance® Introduces Advanced In Vitro ADME and Toxicology Se..
10/14 SIGMA ALDRICH : Cerilliant Introduces Stable-Labeled Certified Reference Materia..
10/09 SIGMA ALDRICH : Expands the Ascentis Express U/HPLC Column Line with addition of..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF